KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells. [electronic resource]
Producer: 20120403Description: 1450-8 p. digitalISSN:- 1528-0020
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western
- Boronic Acids -- pharmacology
- Bortezomib
- Cell Line, Tumor
- Cell Survival -- drug effects
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Hydroxamic Acids -- pharmacology
- Indoles
- Kruppel-Like Transcription Factors -- genetics
- Multiple Myeloma -- genetics
- Oligonucleotide Array Sequence Analysis
- Panobinostat
- Promoter Regions, Genetic -- genetics
- Protein Binding
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Pyrazines -- pharmacology
- RNA Interference
- Reverse Transcriptase Polymerase Chain Reaction
- Transcription Factors -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.